Key information made simple
This EU CTR study explores how the microbiome may affect depression treatment and response. The public Dutch protocol is marked as transitioned, which the app maps to ongoing.
OngoingEUCTR 2021-006510-36
Exploring the Pharmacomicrobiomics of Depression
This study is ongoing. It focuses on depression and currently lists study information in the Netherlands.
DepressionOther
Your next step
The public record does not provide enough detail to summarize the visit format or participation steps clearly. Check the official source for the exact eligibility criteria, locations, contact details, and current recruiting status before taking any next step.
Key study information
- Condition
- Major Depressive Disorder; Adults, Elderly
- Study status
- Ongoing
- Sponsor / lead affiliation
- Radboudumc
- Location / country
- Netherlands
- Registry
- EU CTR
Why this study may matter
This study may matter because it adds public evidence around depression. HopeStage presents it as a starting point for understanding the study, checking the official source, and preparing questions with a care team.
Questions to ask before joining
- What are the exact eligibility criteria, and what could exclude someone?
- How many visits, assessments, or follow-ups are expected, and over what period?
- What risks, side effects, practical burdens, or alternatives should be understood first?
- Who should be contacted to confirm locations, timing, compensation, and next steps?
Registry reference
This page links back to the public source record so people can verify details directly with the registry and research team.
If you want the full study description, eligibility criteria, locations, and sponsor information in the original format, this is the place to check before taking the next step.
Open source recordAsk HopeStage to review this study with me
This form records your interest so HopeStage can follow up with practical guidance. It is not a medical eligibility decision and it does not guarantee a study spot.
Study reference: EUCTR 2021-006510-36. We only ask for your email here. HopeStage can help you review the study, but this is not a medical eligibility decision.
For you
Taking part may help improve understanding of your condition.
It requires a lighter follow-up, often with questionnaires or check-ins.
Not medical advice
Information from public sources. Are you the study sponsor? Contact us to update this page: hi@hopestage.com
Things to check before joining
- Sponsor
- Radboudumc
- Sponsor type
- Unknown or unclear
- Main activity
- digital app or tool
- Intervention
- Not available
- Time commitment
- multiple visits or assessments
- Study phase
- Not available
- Enrollment
- Not available
- Recruitment status
- Ongoing
- Source
- Official registry link
Questions about this study
What is Exploring the Pharmacomicrobiomics of Depression?
This study is exploring digital app or tool for people with depression. Participants may complete study visits, assessments, or follow-up activities defined by the research team. Direct benefit is not guaranteed.
Who is behind this study, and what type of sponsor is it?
This study is sponsored by Radboudumc. We could not clearly classify the sponsor type from the available data. Check the official source record to verify who is responsible for the study.
What does participation involve, what phase is it, and what should I ask about safety?
This study may involve digital app or tool, study visits, and assessments. The time commitment is multiple visits or assessments. The study phase is not available in HopeStage data. Check the official source record to see whether a phase is listed. Enrollment is not available in HopeStage data. HopeStage cannot say whether a study is safe or right for you. Before joining, ask the research team about possible risks, time commitment, visits, side effects, compensation, safety monitoring, and whether participation may affect your current care.
Where can I verify the study details?
Use the official source record linked on this page to check the full study description, recruitment status, eligibility criteria, locations, sponsor information, phase, enrollment, contact details, and any listed risks or requirements.